You searched for "DMO"
Ripasudil after Descemet stripping in Fuch’s endothelial dystrophy
1 June 2019
| Bushra Thajudeen
|
Cornea / External Eye Disease
This study prospectively evaluated the use of ripasudil, a rho kinase inhibitor, in patients undergoing Descemet’s stripping only (DSO) without an endothelial graft for Fuch’s endothelial dystrophy (FED). Patients with dense central guttae limited to the central 5mm of the...
Advances and developments in medical retina
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...Broadening of treatment options for potentially blinding retinal conditions
2 August 2022
| Rod McNeil
|
Ophthalmology
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...
Insights in resistant diabetic macular oedema
5 August 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
This article gives a bird’s eye review of the different modalities for the treatment of diabetic macular oedema (DME). The debut of anti-VEGFs has brought a paradigm shift in DME management. This treatment has now become a major breakthrough in...
In memory of John Hockney, 1948–2024
“I think it is fair to say that John was 'Mr Optrafair' for many years and devoted an enormous amount of his time to ensure it was a financial success for the FMO,” said former FMO Vice-Chairman Kingsley Sleep.A case report of Horner syndrome with neuromyelitis optica
1 August 2014
| Claire Howard
|
Neuro-Ophthalmology
|
Horner syndrome, neuromyelitis optica, NMO IgG antibody
This case report details a patient diagnosed with neuromyelitis optica (NMO) with an associated left Horner syndrome. The female patient presented with neck pain and right hemibody decreased pain and temperature sensation. She then went on to develop left ptosis...
Differential diagnosis of inflammatory optic neuritis
1 February 2014
| Claire Howard
|
Neuro-Ophthalmology
|
Multiple sclerosis, neuromyelitis optica, optic neuritis
The authors present the differential diagnosis of inflammatory optic neuritis (ON) to include multiple sclerosis, infectious optic neuritis, systemic disease and neuromyelitis optica (NMO). The features of ON for the varying aetiologies are detailed including incidence and overlap. In acute...
Cystoid macular oedema following retinal detachment surgery
5 April 2022
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Cystoid macular edema, rhegmatogenous retinal detachment, vitreoretinal surgery
There are limited studies examining the incidence and risk factors for postoperative cystoid macular oedema (CMO) following rhegmatogenous retinal detachment (RRD) repair. Postoperative CMO is thought to be due to pro-inflammatory state, where numerous cytokines lead to tight junction dysfunction,...
An uncommon late postoperative complication of combined cataract surgery and intravitreal triamcinolone injection
1 December 2014
| Pouya Alaghband, Ambreen Kalhoro, Toams Cudrnak, Ishtyak Mahomed, Nigel James
|
AMD, Emergency Ophthalmology, Genetics, Ophthalmology, Optometry, EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Case report A 64-year-old female with diabetic maculopathy (DMO) underwent phacoemulsification with intraocular lens (IOL) implantation in her right eye combined with intravitreal triamcinolone (IVTA). Diabetes control was poor with HbA1c (IFCC) of 119mmol/mol and blood sugar level of 27mmol/L....
100% Optical and Optrafair organisers join forces
27 July 2020
From now on there will be one major annual exhibition, 100% Optical at London’s ExCeL exhibition centre, which has full industry support from the FMO and other major optical bodies.
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
Retina / Uvea / Vitreous
|
Diabetic macular edema (DME), Intravitreal ziv, aflibercept (IVZ), Neovascular age related macular degeneration (n, AMD), Ziv, aflibercept, retinal venous occlusion (RVO)
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...